Data / Form D filings / Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc.: Form D filings
Mythic Therapeutics, Inc., a biotechnology company in Waltham, MA, filed 3 Form D notices with the SEC between 2020 and 2024. The latest, on December 26, 2024, reports $29.9 million sold of a $30.4 million offering to 30 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 BEAVER ST., STE 303, Waltham, MA, 02453
- Phone
- (617) 917-4638
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1819730
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | New notice | $30,444,124 | $29,868,794 | $575,330 | 30 | Dec 9, 2024 | sec.gov |
| Aug 14, 2020 | New notice | $4,749,262 | $4,749,262 | 21 | Jun 11, 2018 | sec.gov | |
| Aug 14, 2020 | New notice | $18,849,989 | $18,849,989 | 18 | Jul 31, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| George Eliades | Executive Officer, Director | |
| Bryan Roberts | Director | |
| Peter Hecht | Director | |
| Sandra Poole | Executive Officer | |
| Brian Fiske | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 23, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mythic Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.